Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Krappmann

Showing results (81-90 of 98) with videos related to

Pageof 10
Sort By:
Journal of Immunotherapy and Precision Oncology|May 22, 2023
Translational Studies Using the MALT1 Inhibitor (<i>S</i>)-Mepazine to Induce Treg Fragility and Potentiate Immune Checkpoint Therapy in CancerMauro Di Pilato, Yun Gao, Yi Sun, et al.
Cell Reports|October 24, 2019
MALT1 Phosphorylation Controls Activation of T Lymphocytes and Survival of ABC-DLBCL Tumor CellsTorben Gehring, Tabea Erdmann, Marco Rahm, et al.
Nature Communications|November 10, 2025
LUBAC modulates CBM complex functions downstream of TRAF6 in T cellsCarina Graß, Franziska Ober, Constanze Sixt, et al.
Nature Communications|April 13, 2016
Alternative splicing of MALT1 controls signalling and activation of CD4(+) T cellsIsabel Meininger, Richard A Griesbach, Desheng Hu, et al.
Molecular Cancer Research : MCR|November 10, 2021
MALT1 Is a Targetable Driver of Epithelial-to-Mesenchymal Transition in Claudin-Low, Triple-Negative Breast CancerJia-Ying Lloyd Lee, Prasanna Ekambaram, Neil M Carleton, et al.
Molecular Cell|March 5, 2013
The E3 ligase parkin maintains mitochondrial integrity by increasing linear ubiquitination of NEMOAnne Kathrin Müller-Rischart, Anna Pilsl, Patrick Beaudette, et al.
The Journal of Pathology|January 23, 2019
Regulation of S1PR2 by the EBV oncogene LMP1 in aggressive ABC-subtype diffuse large B-cell lymphomaMartina Vockerodt, Katerina Vrzalikova, Maha Ibrahim, et al.
Science Immunology|November 12, 2021
TRAF6 prevents fatal inflammation by homeostatic suppression of MALT1 proteaseThomas J O'Neill, Thomas Seeholzer, Andreas Gewies, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 21, 2023
Unrestrained cleavage of Roquin-1 by MALT1 induces spontaneous T cell activation and the development of autoimmunityHenrik Schmidt, Timsse Raj, Thomas J O'Neill, et al.
Nature Immunology|January 5, 2023
Human T<sub>H</sub>17 cells engage gasdermin E pores to release IL-1α on NLRP3 inflammasome activationYing-Yin Chao, Alisa Puhach, David Frieser, et al.
Pageof 10

Showing results (81-90 of 98) with videos related to

Sort By:
Pageof 10
Journal of Immunotherapy and Precision Oncology|May 22, 2023
Translational Studies Using the MALT1 Inhibitor (<i>S</i>)-Mepazine to Induce Treg Fragility and Potentiate Immune Checkpoint Therapy in CancerMauro Di Pilato, Yun Gao, Yi Sun, et al.
Cell Reports|October 24, 2019
MALT1 Phosphorylation Controls Activation of T Lymphocytes and Survival of ABC-DLBCL Tumor CellsTorben Gehring, Tabea Erdmann, Marco Rahm, et al.
Nature Communications|November 10, 2025
LUBAC modulates CBM complex functions downstream of TRAF6 in T cellsCarina Graß, Franziska Ober, Constanze Sixt, et al.
Nature Communications|April 13, 2016
Alternative splicing of MALT1 controls signalling and activation of CD4(+) T cellsIsabel Meininger, Richard A Griesbach, Desheng Hu, et al.
Molecular Cancer Research : MCR|November 10, 2021
MALT1 Is a Targetable Driver of Epithelial-to-Mesenchymal Transition in Claudin-Low, Triple-Negative Breast CancerJia-Ying Lloyd Lee, Prasanna Ekambaram, Neil M Carleton, et al.
Molecular Cell|March 5, 2013
The E3 ligase parkin maintains mitochondrial integrity by increasing linear ubiquitination of NEMOAnne Kathrin Müller-Rischart, Anna Pilsl, Patrick Beaudette, et al.
The Journal of Pathology|January 23, 2019
Regulation of S1PR2 by the EBV oncogene LMP1 in aggressive ABC-subtype diffuse large B-cell lymphomaMartina Vockerodt, Katerina Vrzalikova, Maha Ibrahim, et al.
Science Immunology|November 12, 2021
TRAF6 prevents fatal inflammation by homeostatic suppression of MALT1 proteaseThomas J O'Neill, Thomas Seeholzer, Andreas Gewies, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 21, 2023
Unrestrained cleavage of Roquin-1 by MALT1 induces spontaneous T cell activation and the development of autoimmunityHenrik Schmidt, Timsse Raj, Thomas J O'Neill, et al.
Nature Immunology|January 5, 2023
Human T<sub>H</sub>17 cells engage gasdermin E pores to release IL-1α on NLRP3 inflammasome activationYing-Yin Chao, Alisa Puhach, David Frieser, et al.
Pageof 10